Journal:JBSD:4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 5: Line 5:
<b>Molecular Tour</b><br>
<b>Molecular Tour</b><br>
The key event in prion diseases is the conformational conversion from the cellular form of the prion protein (PrPC) to its pathogenic scrapie form PrPSc (or prion). PrPSc is the sole causative agent of prion diseases which self-propagates by converting PrPC to nascent PrPSc. Mutations in the open reading sequence of the prion protein gene can introduce changes in the protein structure and alter PrPSc formation and propagation, possibly by (de)stabilizing the physiological folding of PrPC and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrPC from being converted to PrPSc, with the so-called “dominant-negative” effect.
The key event in prion diseases is the conformational conversion from the cellular form of the prion protein (PrPC) to its pathogenic scrapie form PrPSc (or prion). PrPSc is the sole causative agent of prion diseases which self-propagates by converting PrPC to nascent PrPSc. Mutations in the open reading sequence of the prion protein gene can introduce changes in the protein structure and alter PrPSc formation and propagation, possibly by (de)stabilizing the physiological folding of PrPC and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrPC from being converted to PrPSc, with the so-called “dominant-negative” effect.
-
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: 1HJN) and in WT MoPrP (PDB: 1XYX). The Mo PrP variants investigated here contain one or two residues from Homo sapiens and are denoted “MoPrP chimeras”. Some of them are resistant to PrPSc infection in in vivo or in in vitro cell-culture experiments, the others are not.
+
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: 1HJN) and in WT MoPrP (PDB: 1XYX). The Mo PrP variants investigated here contain one or two residues from Homo sapiens and are denoted “MoPrP chimeras”. Some of them are resistant to PrPSc infection in ''in vivo'' or in ''in vitro'' cell-culture experiments, the others are not.
Our main results are the following:
Our main results are the following:
(i) The chimeras resistant to PrPSc infection show shorter intramolecular distances between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras. This is due to stronger specific interactions between these two regions, mainly the Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds and the R156-E196 salt bridge (Fig. 1).
(i) The chimeras resistant to PrPSc infection show shorter intramolecular distances between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras. This is due to stronger specific interactions between these two regions, mainly the Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds and the R156-E196 salt bridge (Fig. 1).

Revision as of 11:20, 22 July 2012

Drag the structure with the mouse to rotate
  1. REF

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools